These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11285994)

  • 1. Calcitonin.
    Silverman SL
    Rheum Dis Clin North Am; 2001 Feb; 27(1):187-96. PubMed ID: 11285994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin for prevention and treatment of osteoporosis.
    Reginster JY
    Am J Med; 1993 Nov; 95(5A):44S-47S. PubMed ID: 8256795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.
    Plosker GL; McTavish D
    Drugs Aging; 1996 May; 8(5):378-400. PubMed ID: 8935399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin for prevention and treatment of postmenopausal osteoporosis.
    Body JJ
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():18-21. PubMed ID: 8846656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin.
    Silverman SL
    Endocrinol Metab Clin North Am; 2003 Mar; 32(1):273-84. PubMed ID: 12699303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
    Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
    Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcitonin].
    Nakano T
    Clin Calcium; 2008 Oct; 18(10):1460-8. PubMed ID: 18830043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin.
    Silverman SL
    Am J Med Sci; 1997 Jan; 313(1):13-6. PubMed ID: 9001161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine.
    Szücs J; Horváth C; Kollin E; Szathmári M; Holló I
    Calcif Tissue Int; 1992 Jan; 50(1):7-10. PubMed ID: 1739873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
    Neer RM; Arnaud CD; Zanchetta JR; Prince R; Gaich GA; Reginster JY; Hodsman AB; Eriksen EF; Ish-Shalom S; Genant HK; Wang O; Mitlak BH
    N Engl J Med; 2001 May; 344(19):1434-41. PubMed ID: 11346808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 5-year treatment with elcatonin and alfacalcidol on lumbar bone mineral density and the incidence of vertebral fractures in postmenopausal women with osteoporosis: a retrospective study.
    Iwamoto J; Takeda T; Ichimura S; Uzawa M
    J Orthop Sci; 2002; 7(6):637-43. PubMed ID: 12486466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group.
    Nevitt MC; Ross PD; Palermo L; Musliner T; Genant HK; Thompson DE
    Bone; 1999 Nov; 25(5):613-9. PubMed ID: 10574584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early effect of nasal salmon calcitonin on the bone marker Crosslaps.
    Ofluoglu D; Karadag-Saygi E; Canbulat C; Gunduz OH; Kul-Panza E; Akyuz G
    Rheumatol Int; 2006 Feb; 26(4):288-91. PubMed ID: 15875189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin for osteoporosis and bone pain.
    Mehta NM; Malootian A; Gilligan JP
    Curr Pharm Des; 2003; 9(32):2659-76. PubMed ID: 14529539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis.
    Delmas PD
    Bone; 2002 Jan; 30(1):14-7. PubMed ID: 11792559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of high turnover osteoporosis with calcitonin.
    Reginster JY
    Bone; 1992; 13 Suppl 2():S37-40. PubMed ID: 1627413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal salmon calcitonin in postmenopausal osteoporosis: effect of different therapeutic regimens on vertebral and peripheral bone density.
    Perrone G; Galoppi P; Valente M; Capri O; D'Ubaldo C; Anelli G; Zichella L
    Gynecol Obstet Invest; 1992; 33(3):168-71. PubMed ID: 1612530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study.
    Rico H; Revilla M; Hernández ER; Villa LF; Alvarez de Buergo M
    Calcif Tissue Int; 1995 Mar; 56(3):181-5. PubMed ID: 7750020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.